341 related articles for article (PubMed ID: 24936422)
1. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.
Majid T; Ali YO; Venkitaramani DV; Jang MK; Lu HC; Pautler RG
Neuroimage Clin; 2014; 4():711-7. PubMed ID: 24936422
[TBL] [Abstract][Full Text] [Related]
2. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
3. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
[TBL] [Abstract][Full Text] [Related]
4. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
Kim J; Choi IY; Duff KE; Lee P
Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
6. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.
Sahara N; Perez PD; Lin WL; Dickson DW; Ren Y; Zeng H; Lewis J; Febo M
Neurobiol Aging; 2014 Jun; 35(6):1364-74. PubMed ID: 24411290
[TBL] [Abstract][Full Text] [Related]
7. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
8. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
9. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
10. Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia.
Cook C; Dunmore JH; Murray ME; Scheffel K; Shukoor N; Tong J; Castanedes-Casey M; Phillips V; Rousseau L; Penuliar MS; Kurti A; Dickson DW; Petrucelli L; Fryer JD
Neurobiol Aging; 2014 Jul; 35(7):1769-77. PubMed ID: 24503275
[TBL] [Abstract][Full Text] [Related]
11. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
Radford H; Moreno JA; Verity N; Halliday M; Mallucci GR
Acta Neuropathol; 2015 Nov; 130(5):633-42. PubMed ID: 26450683
[TBL] [Abstract][Full Text] [Related]
12. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
[TBL] [Abstract][Full Text] [Related]
13. Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
Parka A; Volbracht C; Hall B; Bastlund JF; Nedergaard M; Laursen B; Botta P; Sotty F
J Alzheimers Dis; 2023; 93(1):247-262. PubMed ID: 37005884
[TBL] [Abstract][Full Text] [Related]
14. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
15. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
16. Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.
Harrison IF; Whitaker R; Bertelli PM; O'Callaghan JM; Csincsik L; Bocchetta M; Ma D; Fisher A; Ahmed Z; Murray TK; O'Neill MJ; Rohrer JD; Lythgoe MF; Lengyel I
Acta Neuropathol Commun; 2019 Jan; 7(1):4. PubMed ID: 30616676
[TBL] [Abstract][Full Text] [Related]
17. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.
Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP
Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964
[TBL] [Abstract][Full Text] [Related]
19. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
20. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
